HCPCS drug code for golimumab given by IV infusion in a clinic, billed per 1 mg, used for rheumatoid and psoriatic arthritis and ankylosing spondylitis.
- Medicare
- $0.00
- Work RVU
- 0
- Global, days
- Region
- General
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 3 cited references ↓
- Diagnosis supporting IV golimumab
- Patient weight and mg per kg dose
- Units billed (1 unit per mg)
- Infusion start and stop times
- NDC, lot, and discarded amount
- Last infusion date in pre-op notes
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 3 cited references ↓
J1602 reports golimumab for IV use (Simponi Aria) per 1 mg. The subcutaneous Simponi pen that patients use at home is a pharmacy benefit drug and does not go on J1602.
Orthopedic groups see golimumab in surgical candidates with inflammatory arthritis. Ankylosing spondylitis patients come to spine clinics, rheumatoid patients come for hand and foot reconstruction, and all of them carry the infection risk that goes with TNF blockers. Simponi Aria is dosed every eight weeks, so the last infusion date is what the surgeon needs for timing.
If an infusion suite in the group bills it, payment comes from the ASP file, not the physician fee schedule. Units equal mg, so a 2 mg/kg dose on an 80 kg patient is 160 units. Bill IV infusion administration on its own line with start and stop times. Single-dose vials take JW for discarded drug or JZ when none was wasted.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 0 |
| Practice expense RVU | 0 |
| Malpractice RVU | 0 |
| Total RVU | 0 |
| Medicare national rate | $0.00 |
| Global period | days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $0.00 |
HOPD (APC 1475) Hospital outpatient department | $11.63 |
Common denial reasons
The recurring reasons claims for CPT J1602 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Subcutaneous product billed as J1602
- Units billed per vial instead of per mg
- Missing JW or JZ modifier
- No prior authorization
- Step therapy requirement not documented
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 3 cited references ↓
01How many units of J1602 for 160 mg?
02Is Simponi pen billed as J1602?
03How far before surgery should Simponi Aria be dosed?
Sources & references
Editorial content was developed using the following public sources.
- 01CMS Physician Fee Schedule 2026
- 02CMS Medicare Part B Drug Average Sales Price files
- 03cms.govhttps://www.cms.gov/medicare/payment/fee-schedules/physician
Mira Scribe
Mira Scribe notes capture the biologic, its schedule, and the last infusion date at the surgical consult, so timing decisions are documented before the case is booked.
See how Mira captures CPT J1602 documentation